Hormone replacement therapy and cardiovascular disease revisited

Menopause International

Volumn 15, Issue 2, 2009, Pages 55-57

  Stevenson, John C ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ESTROGEN; GESTAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PROGESTERONE;

BLOOD PRESSURE REGULATION; BREAST CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES CONTROL; DIET THERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EXERCISE; HEALTH HAZARD; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MENOPAUSAL SYNDROME; POSTMENOPAUSE; SHORT SURVEY; SMOKING CESSATION; STROKE; VENOUS THROMBOEMBOLISM;

EID: 67649939220     PISSN: 17540453     EISSN: 17540461     Source Type: Journal    
DOI: 10.1258/mi.2009.009018     Document Type: Editorial

References (22)

1. Rees M, Stevenson J. Primary prevention of coronary heart disease. Menopause Int 2008; 14: 40–45
2. NAMS. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of the North American Menopause Society. Menopause 2008; 13: 584–601
3. Pines A, Sturdee DW, Birkhäuser MH,, et al. HRT in the early menopause: scientific evidence and common perceptions. Climacteric 2008; 11: 267–72
4. Stevenson JC. Menopausal hormone therapy. In: Wenger NK, Collins P, eds. Women & Heart Disease. London: Taylor & Francis, 2005: 375–90
5. Writing group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 221–32
6. Manson JE, Hsia J, Johnson KC,, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523–34
7. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004; 291: 1701–12
8. Hsia J, Langer RD, Manson ME,, et al. Conjugated equine estrogens and coronary heart disease. Arch Intern Med 2006; 166: 357–65
9. Manson JE, Allison MA, Rossouw JE,, et al. Estrogen therapy and coronary-artery calcification. N Eng J Med 2007; 365: 2591–602
10. Rossouw JE, Prentice RL, Manson JE,, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465–77
11. Stevenson JC. HRT and cardiovascular disease. Best Pract Res Clin Obstet Gynaecol 2009; 23: 109–20
12. Million Women Study collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419–27
13. Anderson GL, Chlebowski RT, Rossouw JE,, et al. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas 2006; 55: 103–15
14. Stefanick ML, Anderson GL, Margolis KL,, et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 2006; 295: 1647–57
15. Whitehead M, Farmer R. The Million Women Study: a critique. Endocrine 2004; 24: 187–94
16. Bluming AZ. Hormone replacement therapy: the debate should continue. Geriatrics 2004; 59: 30–37
17. Yusuf S, Hawken S, Ounpuu S,, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–52
18. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295: 306–13
19. Walsh JME, Pignone M. Drug treatment of hyperlipidemia in women. JAMA 2004; 291: 2243–52
20. Hodis HN, Mack WJ. Postmenopausal hormone therapy in clinical perspective. Menopause 2007; 14: 1–14
21. Harman SM, Brinton EA, Cedars M,, et al. KEEPS: the Kronos Early Eastrogen Prevention Study. Climacteric 2005; 8: 3–12
22. ELITE: Early versus Late Intervention Trial with Estradiol. http://clinicaltrials.gov/ct2/show/NCT00114517 ( last accessed 16 March 2009)